Strona główna
  • Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka
Advances in Oncology, 2024

Advances in Oncology, 2024

9780443247002
937,39 zł
796,78 zł Zniżka 140,61 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 796,78 zł
Ilość
Od 4 do 6 tygodni

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DHL, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Opis
Advances in Oncology reviews the year’s most important findings and updates within the field in order to provide practicing oncologists with the current clinical information they need to improve patient outcomes. A distinguished editorial board, led by Dr. Leonidas C. Platanias, identifies key areas of major progress and controversy and invites preeminent specialists to contribute original articles devoted to these topics. These insightful overviews in oncology inform and enhance clinical practice by bringing concepts to a clinical level and exploring their everyday impact on patient care.
Szczegóły produktu
Elsevier
100429
9780443247002
9780443247002

Opis

Rok wydania
2024
Numer wydania
1
Oprawa
twarda
Liczba stron
240
Wymiary (mm)
191 x 235
Waga (g)
800
  • 1. Contemporary Management of Dermatofibrosarcoma Protuberans
    2. Management of Locoregional Melanoma
    3. Current Management of Intraductal Papillary Mucinous Neoplasms
    4. Perioperative Strategies in Non-Small Cell Lung Cancer: Immunotherapy and Targeted Therapy
    5. Optimal Front-Line Therapy for Non[1]Oncogene-Driven Non-Small Cell Lung Cancer
    6. Beyond First-Line Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitors (TKI): Approach to Resistance
    7. Antibody-Drug Conjugates for the Treatment of Gynecologic Cancer: A Review of the Current Evidence and Clinical Application
    8. Surgery for Recurrent Ovarian Cancer
    9. Big Data in Pediatric Oncology: Hope, Hype, Reality
    10. Imipridones and Dopamine Receptor Antagonism in the Therapeutic Management of Gliomas
    11. Diagnostic and Theranostic Opportunities in Neuro-Oncology
    12. Updates on Revised Diagnostic Criteria and Targeted Therapies for Neurofibromatosis
    13. Management of Relapsed Refractory Large B[1]Cell Non-Hodgkin Lymphoma: Chimeric Antigen Receptor T-Cell Therapy versus Autologous Stem Cell Transplantation
    14. T-cell Acute Lymphoblastic Leukemia: Novel Therapies Worth Watching
    15. Prognostic Role and Clinical Utility of Measurable Residual Disease in Acute Myeloid Leukemia
    16. Role of Circulating Tumor DNA for Monitoring of Recurrence and Treatment Response in Urothelial Cancer
    17. Intensification of Androgen Deprivation Therapy in Metastatic Hormone-sensitive Prostate Cancer: 18. Patient Selection and Overview of Doublet and Triplet Therapy Data
    19. Adjuvant Therapy for Muscle-Invasive Urothelial Cancer: Current Evidence and Future Directions
    20. Defining the Role of Neoadjuvant Therapy for Gastroesophageal Cancers
    21. Current and Emerging Therapeutic Options for Human Epidermal Growth Factor Receptor 2-Expressing Gastroesophageal Cancers
    22. Contemporary Systemic Therapy Approaches for Unresectable Hepatocellular Carcinoma
    23. Multidisciplinary Care and Multimodal Treatment Approaches for Unresectable Hepatocellular Carcinoma
Komentarze (0)
Ostatnio przeglądane